Farther Finance Advisors, LLC Arbutus Biopharma Corp Transaction History
Farther Finance Advisors, LLC
- $2.77 Trillion
- Q4 2024
A detailed history of Farther Finance Advisors, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 8,000 shares of ABUS stock, worth $26,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$26,640
Previous $30.8 Million
15.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
163Shares Held
99.6MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$72.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$42.9 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$27.9 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $499M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...